QA: AGILE THERAPEUTICS INC in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001261249_2019_AGILE_THERAPEUTICS_INC.pdf

Logs

info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001261249')"}

Graph

Absolute values for 0001261249, AGILE THERAPEUTICS INC

  xvar xval
0 AssetsCurrent 8,458,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 13,916,000
3 remainder_Assets 18,000
4 LiabilitiesCurrent 2,218,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 8,739,000
9 ResearchAndDevelopmentExpense 9,777,000
10 remainder_Expenses 542,000
11 remainder_Revenues 0
12 remainder_NetIncome -721,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 22,392,000
1 Liabilities 2,218,000
2 Expenses 19,058,000
3 Revenues 0
4 StockholdersEquity 20,174,000
5 NetIncome -19,779,000
6 ComprehensiveNetIncome -19,779,000
7 BaseVar 22,194,500
8 EconomicCapitalRatio 1.21

Edgar->Model Mapping

Feature Distribution

Change over Time